Heron Therapeutics

Updates from The Motley Fool

Latest updates on Heron Therapeutics from Fool.com.
7 Stocks to Buy in January

These timely picks could offer a great start to investing in the new year.

Avoid This Pharma Stock

Our investing community's latest prime pick to avoid: AP Pharma.

Stock Performance

View Interactive HRTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Heron Therapeutics.
Current Price: $15.35
Prev Close: $15.25
Open: $15.25
Bid: $14.00
Ask: $15.45
Day's Range: $14.75 - $15.40
52wk Range: $12.21 - $24.00
Volume: 448,993
Avg Vol 579,774
Market Cap: $822M
P/E (ttm): -3.34
EPS (ttm): ($4.56)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Heron Therapeutics.
CAPS Rating 2 out of 5
18 Outperform
10 Underperform
CAPS All Stars
5 Outperform
5 Underperform

How do you think Heron Therapeutics will perform against the market?

You pick for Heron Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Heron Therapeutics.

Heron Therapeutics

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers